Your TRT Clinic Didn't Check the One Hormone That Matters Most

Your testosterone is low. The clinic runs the standard panel, sees the number, and writes the prescription. That is the whole appointment.

What they almost never do is ask why the number is low in the first place.

To understand why that matters, you need to understand how testosterone gets made. Your hypothalamus sends a signal called GnRH down to your pituitary gland, and your pituitary responds by releasing something called LH, which stands for luteinizing hormone. LH travels through the bloodstream to your testes, where it tells a specific type of cell called a Leydig cell to produce testosterone. That is the chain. Hypothalamus to pituitary to testes. And every link in that chain depends, in ways most clinics never check, on your thyroid.

Your thyroid produces two hormones. The first is T4, which is the storage form, and the second is T3, which is the active form. T4 does very little on its own. Your body has to convert it into T3 using enzymes called deiodinases before it becomes usable, and T3 is what actually does the work inside your cells.

When thyroid function is low, what most people picture is fatigue and weight gain. What they do not picture is their testosterone production quietly shutting down through three completely separate mechanisms.

The first mechanism is at the pituitary. T3 controls how well your pituitary responds to the GnRH signal coming down from your hypothalamus. Without adequate T3, the pituitary receives the signal but does not pass it along with enough strength, so LH output drops, and with less LH reaching the testes, testosterone production falls. The whole chain loses pressure at the second link.

The second mechanism is inside the Leydig cell itself. This is where T3 does something very specific. It controls the expression of something called StAR protein, which stands for steroidogenic acute regulatory protein, and what it does is transport cholesterol into the mitochondria inside the Leydig cell. Cholesterol is the raw material testosterone is built from, and the mitochondria is where that conversion starts. StAR is the door. If StAR is not functioning well, the raw material cannot get in, and production stalls regardless of how much LH is showing up. Research on mouse Leydig cells found that T3 increases StAR protein expression by 260 percent, which is not a marginal effect. It is the difference between the factory running and the factory sitting dark with the workers waiting outside.

The third mechanism is in your liver, where T3 regulates the production of something called SHBG, which stands for sex hormone binding globulin. SHBG binds to testosterone in your bloodstream and makes it unavailable for your tissues to use. Only the testosterone that is not bound to SHBG, what labs report as free testosterone, can actually act on your cells. When thyroid is low, SHBG tends to rise, and a larger percentage of whatever testosterone you are producing gets locked up and rendered inactive.

So you have suppressed LH signaling, impaired production at the Leydig cell, and more of the testosterone you do produce being rendered unavailable. Three mechanisms, all pointing in the same direction, all driven by the same underlying thyroid deficiency.

A study published in Clinical Endocrinology looked at men who had documented hypothyroidism and measured their testosterone before and after thyroid treatment. Their free testosterone went from 161 to 315 pmol/L after thyroxine replacement alone, nearly doubling, with no testosterone therapy involved. The thyroid was the problem, thyroid treatment was the solution, and testosterone normalized as a downstream result.

The standard clinic visit does not find this because the standard clinic visit does not look for it.

Most clinics that do check the thyroid at all run only TSH, which is the hormone your pituitary releases to stimulate your thyroid. TSH tells you something is off, but it does not tell you where or why. It does not tell you whether your thyroid is making enough T4, whether that T4 is being converted to T3 effectively, or whether something called reverse T3 is accumulating, which is an inactive form of T3 that can block the receptor sites the active T3 needs to work. A full panel means TSH plus free T4, free T3, and reverse T3 together. Each piece tells you something different about where the system is breaking down.

The conversion step between T4 and T3 is worth understanding because it has its own vulnerability. Those deiodinase enzymes that do the converting require selenium to function. Selenium deficiency directly impairs T4 to T3 conversion, which means free T4 can look adequate while free T3 is low, and a TSH number can look normal because the pituitary is responding to T4 in the blood, not to T3 inside the cells. Research has confirmed that selenium deficiency is associated with a high free T4 to T3 ratio, exactly the pattern you would expect if conversion was impaired. This is a place where a simple dietary deficiency creates a hormone problem that looks, on a basic panel, like it is not there.

If your testosterone is low and your thyroid has never been fully assessed, the practical step is to request the full panel before making any decisions about TRT. If free T3 is low relative to T4, if reverse T3 is elevated, if TSH is drifting upward, those are the things worth addressing first. Selenium adequacy is worth checking in that same conversation.

Testosterone replacement solves the number. It does not solve the system that produced the wrong number. And if the thyroid is what drove testosterone down, adding testosterone from outside while the underlying mechanism stays broken means you are managing a symptom permanently instead of correcting a cause once.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement. Source
2. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers and StAR protein expression 260% increase in Leydig cells. Source
3. Krassas GE, et al. 2010. The male and female reproductive systems in hypothyroidism. Thyroid hormones modulate HPG axis at multiple levels including pituitary LH response, direct Leydig cell effects, and SHBG regulation. Source
4. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness